SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
31584Bob Avinza was developed by Elan. This company licensed North American marketinIcebrg-3/31/2005
31583Few weeks ago, due to yahoo mb idiots, someone on the yahoo board started a modeExtra Pale-3/31/2005
31582i've been in and out lgnd for many years and lucky to be out now but still fbob zagorin-3/31/2005
31581About messages - does anyone know of an active board being used for LGND while tcaptrc-3/31/2005
31580Ligand Pharmaceuticals (LGNDE:Nasdaq - commentary - research) traded actively afdavid nordic-3/31/2005
31579Some questions to you Marvin: Are you a physician investigator? Are you a biostMonte High-3/31/2005
31578You'd understand if you were a teenager and had to look in the mirror every keokalani'nui-3/31/2005
31577"Targretin is not dead. We just did not meet 30% improved survival. DNA Avabiostruggle-3/31/2005
31576Forest Labs (FRX:NYSE - commentary - research) may be in focus Thursday after andavid nordic-3/31/2005
31575Yahoo boards - any news about them?captrc-3/31/2005
31574This company is just starting. The new accounting rules will help stop creative david nordic-3/31/2005
31573I've spent the past week wondering why this thread is entitled Ligand BreakoEdscharp-3/31/2005
31572Thanks. I did buy a little after hours at 5.50.tom pope-3/30/2005
31571i dont think they will be delisted since many other companies ran into similar psammaster-3/30/2005
31570They do look encouraging, but after market is subdued - 5.50. I don't belietom pope-3/30/2005
31569Actually, Ainza sleep trial results look pretty solid. Might be interesting tomtuck-3/30/2005
31568Well, Ian you could be both right and wrong. I re-read the press release and toMonte High-3/30/2005
31567Biotechs with huge sunk costs in a worthless molecule often take too long to kilIan@SI-3/30/2005
31566Targretin NSCLC did not meet the primary or secondary endpoints. These endpointsdavid nordic-3/30/2005
31565Following up on T.D.'s post, here is the text for those who want to listen. tom pope-3/30/2005
31564<i>Been there before... </i> Haven't been here long, though.nigel bates-3/30/2005
31563Lgnd over the past several conferences durning the past year has reduce their prdavid nordic-3/29/2005
31562<I> I joined the LGND longs this afternoon. </i> Would you invite tom pope-3/29/2005
31561"Ligand is reviewing the accounting and classification of its sales of royafred hayes-3/29/2005
31560Regarding Buyout. With the books locked up, how can anybody buy them. That is exdavid nordic-3/29/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News